PT3095866T - Agente de profilaxia e terapia de infeções virais - Google Patents

Agente de profilaxia e terapia de infeções virais

Info

Publication number
PT3095866T
PT3095866T PT15168512T PT15168512T PT3095866T PT 3095866 T PT3095866 T PT 3095866T PT 15168512 T PT15168512 T PT 15168512T PT 15168512 T PT15168512 T PT 15168512T PT 3095866 T PT3095866 T PT 3095866T
Authority
PT
Portugal
Prior art keywords
prophylaxis
therapy
agent
viral infections
infections
Prior art date
Application number
PT15168512T
Other languages
English (en)
Inventor
Potaczek Daniel
Garn Holger
Renz Harald
Original Assignee
Secarna Pharmaceuticals Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secarna Pharmaceuticals Gmbh & Co Kg filed Critical Secarna Pharmaceuticals Gmbh & Co Kg
Publication of PT3095866T publication Critical patent/PT3095866T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/711Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/12Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/127DNAzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/10Applications; Uses in screening processes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/30Special therapeutic applications
    • C12N2320/31Combination therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT15168512T 2015-05-20 2015-05-20 Agente de profilaxia e terapia de infeções virais PT3095866T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15168512.0A EP3095866B1 (de) 2015-05-20 2015-05-20 Mittel zur prophylaxe und therapie von virusinfektionen

Publications (1)

Publication Number Publication Date
PT3095866T true PT3095866T (pt) 2019-06-18

Family

ID=53199819

Family Applications (1)

Application Number Title Priority Date Filing Date
PT15168512T PT3095866T (pt) 2015-05-20 2015-05-20 Agente de profilaxia e terapia de infeções virais

Country Status (9)

Country Link
US (1) US20180171339A1 (pt)
EP (1) EP3095866B1 (pt)
JP (1) JP6709279B2 (pt)
DK (1) DK3095866T3 (pt)
ES (1) ES2729676T3 (pt)
HU (1) HUE045242T2 (pt)
PL (1) PL3095866T3 (pt)
PT (1) PT3095866T (pt)
WO (1) WO2016184810A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110607404B (zh) * 2019-10-30 2023-02-03 广西大学 猪肠病毒g型的实时荧光定量pcr检测引物及其试剂盒
US20240344064A1 (en) * 2021-08-04 2024-10-17 1E Therapeutics, Ltd. Guanine-rich deoxyribozymes, compositions and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10322662A1 (de) * 2002-11-06 2004-10-07 Grünenthal GmbH Wirksame und stabile DNA-Enzyme
CA2621964A1 (en) * 2005-09-08 2007-03-15 Avi Biopharma, Inc. Antisense antiviral compound and method for treating picornavirus infection
EP2257308A4 (en) 2008-03-27 2012-06-27 Sanofi Pasteur Biologics Co RECOMBINANT RHINOVIRUS VECTORS
EP2640469A4 (en) 2010-11-15 2015-01-14 Newcastle Innovation Ltd MODULATION OF THE SIGNAL TRANSDUCTION PATH

Also Published As

Publication number Publication date
EP3095866A1 (de) 2016-11-23
EP3095866B1 (de) 2019-05-08
JP6709279B2 (ja) 2020-06-10
DK3095866T3 (da) 2019-06-24
ES2729676T3 (es) 2019-11-05
PL3095866T3 (pl) 2019-09-30
WO2016184810A1 (de) 2016-11-24
HUE045242T2 (hu) 2019-12-30
US20180171339A1 (en) 2018-06-21
JP2018521114A (ja) 2018-08-02

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
HK1251554A1 (zh) 用於治療和預防病毒感染的新的取代的氨基噻唑並嘧啶二酮
HK1248711A1 (zh) 用於治療和預防病毒感染的新的取代的氨基噻唑並嘧啶二酮
ZA201705633B (en) A new quinoline derivative for use in the treatment and prevention of viral infections
IL280769B1 (en) Novel sulfonimidylpurinone compounds and their history for the treatment and prevention of virus infection
EP3247409A4 (en) Viral vectors for prophylaxis and therapy of hemoglobinopathies
IL263368A (en) Prevention and treatment of viral infections
HK1258276A1 (zh) 用於治療hiv的化合物和組合
HK1231402A1 (zh) 治療 型肝炎和 型肝炎病毒感染的方法
EP3509596C0 (en) NORKETOTIFEN FOR THE TREATMENT OF HYPERCYTOKINEMIA AND VIRAL INFECTION
IL256327A (en) Pharmacological preparations for the treatment of viral problems of the eye
HK1252343A1 (zh) 用於治療病毒感染的組合物和方法
HK1255695A1 (zh) 用於治療眼瞼下垂的組合物和方法
RS64798B1 (sr) Upotreba delgocitiniba za lečenje hroničnog ekcema šaka
PT3095866T (pt) Agente de profilaxia e terapia de infeções virais
SI3471732T1 (sl) Liposomi za zdravljenje virusnih infekcij
SG10202010317VA (en) Pyrimidine prodrugs for the treatment of viral infections and further diseases
GB201520019D0 (en) The genome and self-evolution of AI